Faruqi Faruqi LLP Reminds Regencell Bioscience RGC Investors of Upcoming Securities Class Action Deadline Amazon Appoints Amwell CoFounder Dr Roy Schoenberg as New Health Chief USIran Deal Progress Could Reshape Geopolitical Landscape Oil Markets Germanys Trade Minister Visits Beijing as EU Divisions Over China Policy Deepen Federal Holidays 2025 When Banks Are Closed Including Memorial Day UK Exports to US Slide 25 Following Trumps Tariff Measures Turning Trade Surplus into Deficit MGP Ingredients MGPI Q1 2026 Earnings Earnings Surge Past Estimates Yet Stock Edges Lower BankUnited Q1 2026 Earnings EPS Misses Estimates as Revenue Details Remain Undisclosed Omega Healthcare Investors Inc OHI Q1 2026 Earnings Solid EPS Beat Fails to Lift Stock Grupo Aeroportuario del Sureste SA de CV ASR Q1 2026 Earnings EPS Miss Weighs on Shares Despite Steady Traffic Trends ATXG Q1 2025 Earnings Loss per Share of 025 and Stock Decline Highlight Ongoing Challenges Marvell Technology MRVL Faces Pressure Stock Slides 47 Approaching Key Support GAVA Stakes Claim Near Resistance Avalanche ETF Climbs 122 Amid Volume Shift Mission Produce AVO Faces Resistance Pressure Drops Nearly 2 Key Support Levels in Focus Nabors Industries NBR Slides 379 as Energy Sector Headwinds Intensify Brookfield Corporation BN Holds Steady Near 46 as Markets Look for Direction XP Inc Announces Board Changes Ahead of Annual Shareholder Meeting GAING Q1 2026 Earnings Missed EPS Estimates Amid Stable Performance Tuniu TOUR Slides 065 as Travel Sector Faces Mixed Signals Indian Billionaires Accelerate Overseas Acquisitions as Domestic Growth Moderates Why Bonds May Not Protect Portfolios From InflationLed Market Shocks Morgan Stanleys 150Year Study AI Economy Reshapes Labor Demand ATT CEO Highlights BlueCollar Worker Shortage Jay Shetty Inks Podcast Video Deals With Netflix and Spotify Microsoft Appoints Accessibility Veteran to Lead Responsible AI Development Amid Speed vs Safety Tensions Tesla Launches Full SelfDriving Supervised in China After Lengthy Regulatory Hurdles Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal